PFD Management Shares Update PFD/iOI’s FIH Implant
PFD/iOI announces it has cleared the final hurdles in order to move ahead with its First-In-Human implant of its RAD/iKnee technology.
PFD Management Shares Q123 Clinical Progress and Update On CassdermaRx
The FDA and HHS release report discussing the need for better care protocols for patients suffering from chronic wound issues. This support PFD’s efforts with CassdermaRx, one of the medical technology companies in the PFDMOF3001 Opportunity Fund portfolio.
PFD iOI Announces Acquisition of Arburg Freeformer 300-3X For Production Of iKnee
PFD/iOI has announced the purchase of the Arburg Freeformer 300-3X 3D printer to start prototype development and manufacture of its iKnee technology. The printer is to be installed at PFD/iOI’s new clean room lab at its Los Angeles facility.
PFD Management Shares End of Year HHS Public Access Author Manuscript Recognition from CassdermaRx
The FDA and HHS release report discussing the need for better care protocols for patients suffering from chronic wound issues. This support PFD’s efforts with CassdermaRx, one of the medical technology companies in the PFDMOF3001 Opportunity Fund portfolio.
World Health Organization Says “We’re in a Wound Pandemic”
PFD share information which relates to its partnership with CassdermaRx, one of the portfolio companies in the PFDMOF3001 Opportunity fund. The article published in the C-Street Advisors regards a recent study by the World Health Organization and the National Institutes of Health examining the rising concern over recalcitrant wound growth statistics.
Introducing Dr. Daniel Rastein, Cassderma RX and Castle IRB
In this release, PFD shares an update on Dr. Daniel Rastein, MD, MPH who is the Founder & CEO of Cassderma RX, one of the portfolio companies in the PFDMOF3001 Opportunity Fund. Dr . Rastein has been retained by the PFD team to coordinate the Institutional Review Board Sponsored by Advarra for the PFD/iOrthopedics INC new orthopedic Resilient Arthroplasty Device (RAD) referred to as the iKnee,